Correlation Between Apellis Pharmaceuticals and Reneo Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and Reneo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and Reneo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Apellis Pharmaceuticals and Reneo Pharmaceuticals, you can compare the effects of market volatilities on Apellis Pharmaceuticals and Reneo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of Reneo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and Reneo Pharmaceuticals.

Diversification Opportunities for Apellis Pharmaceuticals and Reneo Pharmaceuticals

0.21

Correlation Coefficient

Apellis Pharmaceuticals  Reneo Pharmaceuticals

Modest diversification

The 3 months correlation between Apellis and Reneo is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and Reneo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reneo Pharmaceuticals and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with Reneo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reneo Pharmaceuticals has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and Reneo Pharmaceuticals go up and down completely randomly.

Pair Corralation between Apellis Pharmaceuticals and Reneo Pharmaceuticals

If you would invest  3,191  in Apellis Pharmaceuticals on September 26, 2024 and sell it today you would earn a total of  141.00  from holding Apellis Pharmaceuticals or generate 4.42% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	4.76%
Values	Daily Returns

Apellis Pharmaceuticals  vs.  Reneo Pharmaceuticals

Apellis Pharmaceuticals

Risk-Adjusted Performance

5 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Apellis Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady essential indicators, Apellis Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Reneo Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Excellent

Over the last 90 days Reneo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very unsteady technical indicators, Reneo Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Apellis Pharmaceuticals and Reneo Pharmaceuticals

The main advantage of trading using opposite Apellis Pharmaceuticals and Reneo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, Reneo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reneo Pharmaceuticals will offset losses from the drop in Reneo Pharmaceuticals' long position.

The idea behind Apellis Pharmaceuticals and Reneo Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..